These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1885064)

  • 21. Actual role of pepsinogen group I in the study of upper gastrointestinal diseases.
    Plebani M; Di Mario F; Vianello F; Farini R; Piccoli A; Lazzaretto L; Perobelli L; Naccarato R; Burlina A
    Clin Biochem; 1983 Oct; 16(5):310-2. PubMed ID: 6652888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptic disease and 24-hr patterns of serum gastrin and pepsinogen.
    Mazzetti di Pietralata M; Cugini P; Bersacchi F; Piccinni Leopardi M; Samaritani R; Leonardi C
    Prog Clin Biol Res; 1987; 227A():389-95. PubMed ID: 3601974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoscopic characteristics of infection-associated peptic ulcers.
    Choi SH; Kim DM; Lee J; Yun NR
    Helicobacter; 2017 Dec; 22(6):. PubMed ID: 28833968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum pepsinogen I levels in bleeding duodenal ulcer].
    Kolster JJ; Castro de Kolster C; Macía de Luco M
    G E N; 1990; 44(2):118-24. PubMed ID: 2152265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and evolutionary implications in peptic ulcer disease.
    Petersen GM; Rotter JI
    Am J Phys Anthropol; 1983 Sep; 62(1):71-9. PubMed ID: 6624902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of duodenal ulcer and elevated serum pepsinogen I levels in smokers and nonsmokers.
    Sumii K; Kimura M; Morikawa A; Haruma K; Yoshihara M; Kajiyama G
    Am J Gastroenterol; 1990 Nov; 85(11):1493-7. PubMed ID: 2239877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An enzyme-linked immunosorbent assay of serum group I pepsinogen using a monoclonal antibody and its clinical application].
    Huang SC; Miki K; Shimizu A; Ichinose M; Oka H; Furihata C; Matsushima T; Hirano K; Hayashi Y
    Nihon Shokakibyo Gakkai Zasshi; 1987 Jan; 84(1):13-9. PubMed ID: 3573381
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma pepsinogen in health and gastroduodenal disorders.
    Naganna B; Balasundaram D; Venkaiah KR
    J Indian Med Assoc; 1972 Jan; 58(1):6-9. PubMed ID: 5021272
    [No Abstract]   [Full Text] [Related]  

  • 30. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM; Taggart RT
    Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duodenal-ulcer disease associated with elevated serum pepsinogen I: an inherited autosomal dominant disorder.
    Rotter JI; Sones JQ; Samloff IM; Richardson CT; Gursky JM; Walsh JH; Rimoin DL
    N Engl J Med; 1979 Jan; 300(2):63-6. PubMed ID: 758579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site and size of bleeding peptic ulcer. Is there any relation to the efficacy of hemostatic sclerotherapy?
    Brullet E; Campo R; Bedos G; Barcons S; Gubern JM; Bordas JM
    Endoscopy; 1991 Mar; 23(2):73-5. PubMed ID: 2050010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay].
    Matsumoto K; Hashimoto K; Samori T; Taniguchi M; Kotera K; Nishi S; Takatsuji M; Higashi K; Itoh K
    Rinsho Byori; 1992 Sep; 40(9):977-81. PubMed ID: 1434035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serum pepsinogen I in children with peptic ulcer.
    Oderda G; Altare F; Dell'Olio D; Ansaldi N
    J Pediatr Gastroenterol Nutr; 1988; 7(5):645-50. PubMed ID: 3183868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of the comorbidity diseases and risk factors on development of the combined peptic ulcer of the stomach and the duodenum].
    Stepanishcheva LA; Sarsenbaeva AS; Fattakhova NV
    Eksp Klin Gastroenterol; 2013; (8):34-40. PubMed ID: 24933946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gastroduodenal incretory cells in duodenal ulcer with different levels of gastric secretion].
    Zverkov IV; Perov IuL; Minushkin ON; Sokolov LK; Maslovskiĭ LV
    Arkh Patol; 1990; 52(10):20-5. PubMed ID: 1980809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.
    Mossi S; Meyer-Wyss B; Renner EL; Merki HS; Gamboni G; Beglinger C
    Gut; 1993 Jun; 34(6):752-6. PubMed ID: 8314506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Link between Serum Pepsinogen Concentrations and Upper Gastrointestinal Endoscopic Findings.
    Lee SP; Lee SY; Kim JH; Sung IK; Park HS; Shim CS
    J Korean Med Sci; 2017 May; 32(5):796-802. PubMed ID: 28378553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Genetic analysis of the indices of gastric acid secretory and proteolytic functions in duodenal ulcer patients].
    Lebedeva RP; Sergeev AS; Kovanova LA
    Genetika; 1985 Feb; 21(2):327-31. PubMed ID: 3886481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic heterogeneity of combined gastric and duodenal ulcers detected by pepsinogen C gene polymorphism.
    Konishi J; Azuma T; Kohli Y; Fujiki N
    J Gastroenterol Hepatol; 1994; 9(4):334-9. PubMed ID: 7948814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.